Postpartum Insulin Management and Hypoglycemia Prevention in Women with Diabetes

Immediate Insulin Adjustment After Delivery

Insulin requirements fall sharply—by roughly 34‑50 %—immediately after placental delivery, so insulin doses must be reduced urgently to avoid severe hypoglycemia (American Diabetes Association) 1, 2.
Insulin resistance declines within minutes of placental expulsion because diabetogenic placental hormones are removed from the circulation (ADA) 1.
Over the subsequent 1‑2 weeks, insulin sensitivity returns to the pre‑pregnancy baseline, necessitating ongoing dose titration (ADA) 1, 2.

Special attention is required to prevent hypoglycemia when mothers are breastfeeding and when sleep‑ and eating‑patterns are erratic (ADA) 1, 3.
Lactation raises the risk of overnight hypoglycemia owing to the high metabolic demand of milk production (ADA) 1, 2.
Insulin regimens should be further lowered during lactation to match the increased glucose utilization for milk synthesis (ADA) 1.

Use of sulfonylureas (e.g., glyburide) during pregnancy adds neonatal hypoglycemia risk because the drug can cross the placenta (ADA) 4.
Umbilical‑cord plasma concentrations of sulfonylureas can reach about 70 % of maternal levels (ADA) 4.
Glyburide exposure is linked to higher neonatal hypoglycemia rates compared with insulin or metformin therapy (ADA) 4.
Post‑delivery, mothers should be switched immediately to insulin at reduced doses rather than restarting sulfonylureas until lactation patterns and maternal glucose stability are confirmed (ADA) 1.

Neonatal hypoglycemia occurs in 10‑40 % of infants of diabetic mothers, driven by persistent fetal hyperinsulinemia for 24‑48 h after the abrupt loss of maternal glucose supply (American Society of Anesthesiologists) 5.
The highest neonatal risk is seen when maternal glycemic control during pregnancy and labor is poor, as indicated by elevated HbA1c values (ASA) 5.
Untreated neonatal hypoglycemia can cause neurological injury, with severity related to the duration and depth of glucose deficits (ASA) 5.

Continuing pregnancy‑dose insulin regimens postpartum is the leading cause of severe maternal hypoglycemia (ADA) 1, 2.
Delaying insulin dose reduction while awaiting “stable” glucose readings is unsafe; the physiologic drop in insulin need is immediate and predictable (ADA) 1.
Irregular sleep schedules with a newborn independently increase hypoglycemia risk, beyond the effect of breastfeeding (ADA) 1, 3.
Hemoglobin A1c should not be used for postpartum diabetes screening at 4‑12 weeks because pregnancy‑related changes lower its value; a 75‑g oral glucose tolerance test is recommended instead (ADA) 1.

The American College of Obstetricians and Gynecologists recommends transitioning to intravenous insulin infusion during cesarean section to prevent maternal hypoglycemia and ketosis, with glucose infusion administered concurrently 6, 7, 8
The American Diabetes Association suggests using the patient's current basal insulin rate as the starting point for intravenous insulin infusion, with adjustments made as needed to maintain blood glucose levels between 110-160 mg/dL 9
Regional anesthesia is preferred over general anesthesia to reduce hyperglycemic stress response 10

The American College of Obstetricians and Gynecologists recommends targeting a blood glucose range of 110-160 mg/dL during cesarean section to support optimal wound healing 8, 11
Avoiding both hyperglycemia and hypoglycemia is crucial, as hyperglycemia increases infection risk and hypoglycemia poses a maternal safety concern 10

The American Diabetes Association recommends resuming basal-bolus insulin regimen at 50% of end-of-pregnancy doses or 80% of pre-pregnancy doses, whichever is documented, to minimize the risk of hypoglycemia and ketoacidosis 6, 7, 8
The Endocrine Society suggests implementing a correction dose sliding scale based on pre-meal and bedtime blood glucose values to maintain blood glucose levels within the target range 6, 7

The American College of Obstetricians and Gynecologists recommends targeting a blood glucose range of 110-160 mg/dL for the first 48 hours post-cesarean to optimize wound healing 8, 11
After 48 hours, the target range can be liberalized to 100-180 mg/dL if wound healing is progressing well 6

The American College of Obstetricians and Gynecologists recommends ensuring patients receive regular meals and snacks once tolerating oral intake to prevent hypoglycemia, and never giving correction insulin without adequate carbohydrate intake 10, 6
The Endocrine Society suggests monitoring for ketosis, especially in patients with Type 1 diabetes or prolonged fasting, and checking urine or serum ketones if blood glucose levels exceed 200 mg/dL or the patient is symptomatic 6, 8

The American Academy of Pediatrics recommends mandatory pediatric assessment at delivery for neonatal hypoglycemia risk and respiratory distress, with consideration of NICU admission for close glucose and respiratory monitoring 12, 10
The American College of Obstetricians and Gynecologists suggests that neonatal hypoglycemia occurs due to fetal hyperinsulinemia persisting 24-48 hours postpartum, and that prompt treatment is necessary to prevent permanent neurological injury 12